Fetal biometry following in-utero exposure to dolutegravir-based or efavirenz-based antiretroviral therapy

MeSH terms

• Alkynes* / administration & dosage
• Alkynes* / adverse effects
• Benzoxazines* / administration & dosage
• Benzoxazines* / adverse effects
• Biometry
• Cyclopropanes* / administration & dosage
• Cyclopropanes* / adverse effects
• Female
• Fetus* / anatomy & histology
• Fetus* / diagnostic imaging
• Fetus* / drug effects
• HIV Infections* / drug therapy
• HIV Integrase Inhibitors / administration & dosage
• HIV Integrase Inhibitors / adverse effects
• Heterocyclic Compounds, 3-Ring* / administration & dosage
• Heterocyclic Compounds, 3-Ring* / adverse effects
• Humans
• Oxazines* / administration & dosage
• Oxazines* / adverse effects
• Piperazines* / administration & dosage
• Piperazines* / adverse effects
• Pregnancy
• Pregnancy Complications, Infectious* / drug therapy
• Pregnancy Complications, Infectious* / virology
• Pyridones* / administration & dosage
• Pyridones* / adverse effects
• Reverse Transcriptase Inhibitors / administration & dosage
• Reverse Transcriptase Inhibitors / adverse effects
• Ultrasonography, Prenatal